Results 71 to 80 of about 4,483 (147)

Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw

Brazilian Dental Science
Osteonecrosis of the jaw associated with bisphosphonate use is a matter of utmost importance in clinical practice for the safe treatment of patients using this medication.
Thainara Alexia Marinho de Souza , Gabriela Ribeiro Zucco, Janete Dias Almeida   +2 more
doaj   +1 more source

Chinese Guideline on Risk Management of Osteoporosis in the General Public

Orthopaedic Surgery, Volume 18, Issue 10, Page 2015-2031, October 2026.
Summary of the background, key recommendations, and expected impact of the public guideline for osteoporosis risk management. ABSTRACT Background Osteoporosis is a common chronic skeletal disorder characterized by decreased bone mass and microarchitectural deterioration, resulting in increased fragility and fracture risk. With rapid population aging in
Shiyong Zhang, Jinqiu Yuan, Zhuojing Luo, Jiacan Su, Weibo Xia, Kehu Yang, Fuxin Wei, Osteoporosis Group, Chinese Association of Orthopaedic Surgeons, Youth Osteoporosis Group, Chinese Orthopaedic Association, Chinese Medical Association, Health Communication Branch, Chinese Preventive Medicine Association, Spine and Joint Health Branch, Guangdong Health Care Association, Chinese Health Risk Management Collaboration–Osteoporosis Group (CHRIMAC‐OP), Zhuojing Luo, Jiacan Su, Weibo Xia, Kehu Yang, Fuxin Wei, Jinqiu Yuan, Xiao Chen, Bo Gao, Yang Guo, Xiaofeng Gong, Junjie Huang, Yafang Huang, Tianyong Hou, Da He, Bin Liu, Yajun Liu, Fangping Li, Ying Li, Wei Li, Jiang Li, Zhihao Li, Xiahong Lin, Houqing Long, Jianwen Mo, Wenfei Ni, Yuanjun Teng, Liang Wang, Xiaobin Wang, Hongli Wang, Nan Wu, Hongfei Xiang, Bin Yan, Dejin Yang, Min Yang, Wei Ye, Hongping Yu, Ziji Zhang, Shiyong Zhang, Xinyu Chen, Ningning Chen, Qiangsheng He, Linmin Hu, Wenjing Li, Zijun Li, Qiji Li, Chengkai Lin, Qingfeng Luo, Tianyi Liu, Ningning Mi, Mina Ma, Jun Shen, Peng She, Huidong Tian, Siqing Wu, Junming Wan, Yongsheng Wang, Bin Xia, Peng Xie, Jinyu Zhao, Fei Zhang, Penghui Zhang, Danni Wang, Lei Cheng, Zhongshi Li, Xinyu Liu, Jing Wang, Shengping Yang, Binsheng Yu   +84 more
wiley   +1 more source

Denosumab-related osteonecrosis of the external auditory canal—benefit of the early surgical management

Ear, Nose & Throat Journal
Background: Antiresorptive drugs are widely used to reduce bone mineral loss in patients with osteoporosis and to prevent skeletal-related events in patients with metastatic cancers and multiple myeloma (MM).
Vojtěch Peřina PhD, Richard Salzman PhD, Jana Treglerová MD   +2 more
doaj   +1 more source

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database

Therapeutics and Clinical Risk Management, 2018
Ayaka Inada, Keiko Hosohata, Saki Oyama, Iku Niinomi, Yasuhiro Mori, Yuki Yamaguchi, Mayako Uchida, Kazunori Iwanaga Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka 569-1094, Japan ...
Inada A, Hosohata K, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K   +7 more
doaj  

How we manage medication-related osteonecrosis of the jaw

European Journal of Medical Research
Bone-modifying agents (BMAs) are integral to managing patients with advanced cancer. They improve quality of survival by reducing skeletal-related events, treating hypercalcaemia and chemotherapy-induced bone loss (Coleman in Clin Cancer Res 12: 6243s ...
H. Byrne, S. O’Reilly, C. S. Weadick, P. Brady, R. Ni Ríordáin   +4 more
doaj   +1 more source

Risk factors of medication-related osteonecrosis of the jaw – a literature review

Medycyna Paliatywna
Medication-related osteonecrosis of the jaw (MRONJ) is one of the most serious complications of therapy with drugs affecting bone metabolism. This review presents current scientific reports on risk factors for MRONJ and then categorizes them according to
Wojciech Paprotny, Daria Wziątek-Kuczmik, Maria Młodzińska, Iwona Niedzielska   +3 more
doaj   +1 more source

Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study

BMC Oral Health
Aim The study aims to retrospectively assess and share the experience of the use of photobiomodulation (PBM) as an adjunctive to surgical extraction in patients at-risk for medication-related osteonecrosis of the jaw (MRONJ) due to a treatment history ...
Gianluca Tenore, Ahmed Mohsen, Alessandro Del Vecchio, Gaspare Palaia, Federica Rocchetti, Lucia Borghetti, Giuseppe Vasile, Francesca Graniero, Umberto Romeo   +8 more
doaj   +1 more source

Non-Surgical Therapy For Denosumab-Associated Jaw Osteonecrosis: Case Report

International Dental Journal
Introduction: This case report describes non-surgical management of denosumab-related osteonecrosis of the jaw to inform treatment strategies for medication-related osteonecrosis of the jaw (MRONJ) in patients with systemic comorbidities.
Junyan Gao, Chunxu Lv
doaj   +1 more source

A Retrospective Cohort Study of Medication-Related Osteonecrosis of the Jaw (MRONJ) Prevention. [PDF]

Oral Health Prev Dent
Baghalipour N, Moztarzadeh O, Othman B, Dehghani Y, Hauer L.   +4 more
europepmc   +1 more source

Small Intramucosal Sequestra in Medication-Related Osteonecrosis of the Jaw: A Case Series. [PDF]

Diagnostics (Basel)
Hayashi U, Koizumi G, Okumura K, Yamada R, Nagata K, Kurohara K, Murata T, Shimizu K, Hayashi A, Yamanaka K, Arai N.   +10 more
europepmc   +1 more source